Effect of eye drops for dry eye, glaucoma and cataract surgery using DEQS (Dry Eye Related Quality of Life Score)

Effect of eye drops for dry eye, glaucoma and cataract surgery using DEQS (Dry Eye Related Quality of Life Score) - Effect of eye drops for dry eye, glaucoma and cataract surgery

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017667

Enrollment

100

Registered

2015-05-25

Start date

2013-06-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry eye, Glaucoma, and Cataract (Cataract surgery)

Interventions

The treatment with each ophthalmic solution for dry eye, glaucoma, or cataract surgery is started. The treatment with each another ophthalmic solution for dry eye, glaucoma, or cataract surgery is sta

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Age of 20 years and over 2) Patients who plan to start the treatment with ophthalmic solution for dry eye 3) Patients who plan to start the treatment with ophthalmic solution for glaucoma 4) Patients who plan to start the treatment with ophthalmic solution for cataract surgery 5) Under the description of the study to understand its significance, written consent is obtained from the patients themselves

Exclusion criteria

Exclusion criteria: 1) Patients who are judged inappropriately for principal investigator

Design outcomes

Primary

Measure	Time frame
Clinical assessments of the conjunctival and corneal fluorescein staining scores, tear film breakup times (BUT), Schirmer's tests, DEQS scores, and tear meniscus areas using anterior segment optical coherence tomography	—

Countries

Japan

Contacts

Public ContactAtsushi Kawahara, Tsugiaki Utsunomiya

Sapporo Tokushukai Hospital Ophthalmology

atsusi-k@coral.plala.or.jp011-890-1110

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026